\n<\/p>\n
Novel Ingredients in Infant Formula Market Size is predicted to grow at 8.7% CAGR during the forecast period for 2025-2034.<\/p>\n
Global Novel Ingredients in Infant Formula Market 2025-2034 full Research Repot latest version is now available.<\/p>\n
Get Free Access to Demo Report, Excel Pivot and ToC: https:\/\/www.insightaceanalytic.com\/request-sample\/2977<\/a><\/p>\n The term “novel ingredients” in infant formula refers to components that exceed the standard nutrients, including protein, fat, carbohydrates, vitamins, and minerals. These innovative substances are added to more closely replicate the composition and potential health benefits of human breast milk. <\/p>\n One such ingredient is the Milk Fat Globule Membrane (MFGM), a complex three-layered membrane that surrounds fat droplets in breast milk. MFGM contains a variety of bioactive components, including phospholipids, proteins such as lactoferrin and osteopontin, and cholesterol. Emerging research suggests that these components may play essential roles in supporting brain development, cognitive function, and immune health in infants. <\/p>\n Thanks to advancements in extraction technology, MFGM can now be isolated and preserved for inclusion in infant formula. Additionally, novel prebiotics non-digestible food components that selectively stimulate the growth and activity of beneficial gut bacteria are being added to formulas. Examples include galacto-oligosaccharides (GOS) and fructo-oligosaccharides (FOS), which help promote a healthy gut microbiome and enhance overall infant well-being.<\/p>\n There is a growing demand for infant formulas enriched with functional ingredients that support key areas of development such as immunity, digestion, and cognitive function. This trend is especially prominent in the specialty formula segment, which is tailored to meet the unique health needs of certain infants. <\/p>\n The incorporation of prebiotics, probiotics, and postbiotics is becoming increasingly common, as these components play a vital role in fostering a healthy gut microbiome and strengthening the immune system. At the same time, advancements in biotechnology have made it possible to produce novel ingredients like human milk oligosaccharides (HMOs) and milk fat globule membrane (MFGM), which closely resemble critical components of human breast milk. These innovations are significantly enhancing the nutritional value and functionality of modern infant formulas.<\/p>\n List of Prominent Players in the Novel Ingredients in Infant Formula Market:<\/p>\n \u0095\tDSM Novel Ingredients in Infant Formula Market Report Scope Expert Knowledge, Just a Click Away: https:\/\/calendly.com\/insightaceanalytic\/30min?month=2025-04<\/a><\/p>\n Market Dynamics: Additionally, the rising prevalence of food allergies, digestive issues, and metabolic disorders among infants has accelerated the demand for specialized and hypoallergenic formulas incorporating novel ingredients. As premium and specialty formulas gain popularity, manufacturers are investing heavily in research and development to deliver products that meet evolving nutritional needs and consumer expectations.<\/p>\n Challenges: Regional Trends: However, North America holds a significant portion of the infant formula ingredients market. The region benefits from supportive government initiatives and a strong emphasis on infant nutrition. The market is characterized by a demand for organic and clean-label products, reflecting consumer preferences for high-quality and transparent ingredient sourcing. <\/p>\n Recent Developments: Unlock Your GTM Strategy: https:\/\/www.insightaceanalytic.com\/customisation\/2977<\/a><\/p>\n Segmentation of Novel Ingredients in Infant Formula Market. About Us: Contact us:
\u0095\tFrieslandCampina
\u0095\tNovonesis (Chr. Hansen + Novozymes)
\u0095\tDuPont (IFF Nutrition)
\u0095\tBASF
\u0095\tAAK
\u0095\tGlycosyn
\u0095\tInbiose
\u0095\tKyowa Hakko
\u0095\tNestl\u00e9
\u0095\tDanone (Nutricia)
\u0095\tAbbott Nutrition
\u0095\tReckitt (Mead Johnson)
\u0095\tArla Foods
\u0095\tFonterra
\u0095\tHelaina
\u0095\tBiomilq
\u0095\t108LABS
\u0095\tTurtletree Labs
\u0095\tElse Nutrition
\u0095\tByHeart
\u0095\tSprout Organic
\u0095\tConagen
\u0095\tNature\u0092s One
\u0095\tBactolife
\u0095\tEvonik
\u0095\tGlycotope<\/p>\n
Report Attribute\tSpecifications
Market Size Value In 2024\tUSD XXX Mn
Revenue Forecast In 2034\tUSD XXX Mn
Growth Rate CAGR\tCAGR of XX % from 2025 to 2034
Quantitative Units\tRepresentation of revenue in US$ Mn and CAGR from 2024 to 2034
Historic Year\t2021 to 2024
Forecast Year\t2024-2034
Report Coverage\tThe forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends
Segments Covered\tBy Ingredient Type, Application, Source
Regional Scope\tNorth America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country Scope\tU.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; South East Asia
Competitive Landscape\tDSM, FrieslandCampina, Novonesis (Chr. Hansen + Novozymes), DuPont (IFF Nutrition), BASF, AAK, Glycosyn, Inbiose, Kyowa, Hakko, Nestl\u00e9, Danone (Nutricia), Abbott Nutrition, Reckitt (Mead Johnson), Arla Foods, Fonterra, Helaina, Biomilq, 108LABS, Turtletree Labs, Else Nutrition, ByHeart, Sprout, Organic, Conagen, Nature\u0092s One, Bactolife, Evonik, Glycotope
Customization Scope\tFree customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape.
Pricing and Available Payment Methods\tExplore pricing alternatives that are customized to your particular study requirements. <\/p>\n
Drivers:
The growing emphasis on infant health and nutrition is a key driver of the novel ingredients in the infant formula market. Consumers, nowadays are more health-conscious and informed, demanding high-quality formulas enriched with ingredients like HMOs, MFGM, and bioengineered proteins that promote immunity, digestion, and cognitive development. <\/p>\n
One of the primary obstacles is the complex and lengthy regulatory approval process, as novel ingredients must meet rigorous safety and efficacy standards before being introduced into infant products. High research and development costs, along with the need for specialized manufacturing technologies<\/p>\n
Asia-Pacific dominates the infant formula market. This leadership is driven by factors such as high birth rates, urbanization, and increasing disposable incomes. Notably, China’s market has expanded due to an improved retail landscape and the relaxation of the one-child policy. However, declining birth rates and an aging population in China are prompting dairy producers to diversify their product lines to include adult nutrition products. <\/p>\n
\u0095\tIn April 2025, DSM-Firmenich received approval from the FSSAI to use GLYCARE 2FL, a human milk oligosaccharide, in early-life nutrition products in India. This comes after the European Commission recently approved dsm-firmenich’s HMO ingredient, LNFP-I. The company also just introduced Dry Vit A Palmitate, an early-life nutraceutical intended to treat vitamin A deficiency. Infants can now use the component 2′-O-Fucosyllactose (2′-FL), with a daily maximum suggested intake of 1.2 grams per liter of formula.
\u0095\tIn Oct 2024, dsm-firmenich, Launched Dry Vit A Palmitate for Early Life Nutrition, a ground-breaking clean-label solution created to improve the nutritional value of newborn formulae without the stability problems associated with conventional vitamin A components, was announced by leaders in health, nutrition, and beauty.
\u0095\tIn Sep 2023, Danone, the head of Danone’s early life nutrition division and vice president announced a new newborn formula in China that contains milk droplets that closely resemble the structure of mothers’ milk, according to Growth Asia.<\/p>\n
Global Novel Ingredients in Infant Formula Market – By Ingredient Type
\u0095\tHuman Milk Oligosaccharides (HMOs)
\u0095\tMilk Fat Globule Membrane (MFGM)
\u0095\tSynthetic\/Bioengineered Proteins
\u0095\tNext-Gen Probiotics
\u0095\tPlant-Based Bioactives
\u0095\tGlycomacropeptides (GMPs)
\u0095\tExosomes and MicroRNAs
Global Novel Ingredients in Infant Formula Market \u0096 By Application
\u0095\tStandard Infant Formula
\u0095\tFollow-On Formula
\u0095\tSpecialty Formula
\u0095\tGrowing-Up Milk
Global Novel Ingredients in Infant Formula Market \u0096 By Source
\u0095\tBioengineered
\u0095\tPlant-Based
\u0095\tAnimal-Derived
Global Novel Ingredients in Infant Formula Market \u0096 By Region
North America-
\u0095\tThe US
\u0095\tCanada
Europe-
\u0095\tGermany
\u0095\tThe UK
\u0095\tFrance
\u0095\tItaly
\u0095\tSpain
\u0095\tRest of Europe
Asia-Pacific-
\u0095\tChina
\u0095\tJapan
\u0095\tIndia
\u0095\tSouth Korea
\u0095\tSoutheast Asia
\u0095\tRest of Asia Pacific
Latin America-
\u0095\tBrazil
\u0095\tArgentina
\u0095\tMexico
\u0095\tRest of Latin America
Middle East & Africa-
\u0095\tGCC Countries
\u0095\tSouth Africa
\u0095\tRest of the Middle East and Africa<\/p>\n
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.<\/p>\n
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com<\/a>
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com <\/p>\n<\/div>\n